These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12352000)

  • 1. Experimental and therapeutic approaches to muscular dystrophies.
    Skuk D; Vilquin JT; Tremblay JP
    Curr Opin Neurol; 2002 Oct; 15(5):563-9. PubMed ID: 12352000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic strategy for muscular dystrophies].
    Shin JH; Takeda S
    Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for muscular dystrophy - a review of promising progress.
    Gregorevic P; Chamberlain JS
    Expert Opin Biol Ther; 2003 Aug; 3(5):803-14. PubMed ID: 12880380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for muscular dystrophies: current status and future prospects.
    Takeda S; Miyagoe-Suzuki Y
    BioDrugs; 2001; 15(10):635-44. PubMed ID: 11604045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of gene therapy for muscle diseases.
    Thirion C; Lochmüller H
    Drug News Perspect; 2007; 20(6):357-63. PubMed ID: 17925889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of an ultrasound-mediated nucleic acid delivery system for treating muscular dystrophies].
    Negishi Y; Hamano N; Shiono H; Akiyama S; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    Yakugaku Zasshi; 2012; 132(12):1383-8. PubMed ID: 23208045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular therapy of muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy research for Duchenne and Becker muscular dystrophies.
    Karpati G; Gilbert R; Petrof BJ; Nalbantoglu J
    Curr Opin Neurol; 1997 Oct; 10(5):430-5. PubMed ID: 9330891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene and Cell Therapy for Muscular Dystrophies: Are We Getting There?
    Galli F; Bragg L; Meggiolaro L; Rossi M; Caffarini M; Naz N; Santoleri S; Cossu G
    Hum Gene Ther; 2018 Oct; 29(10):1098-1105. PubMed ID: 30132372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for muscular dystrophy: moving the field forward.
    Al-Zaidy S; Rodino-Klapac L; Mendell JR
    Pediatr Neurol; 2014 Nov; 51(5):607-18. PubMed ID: 25439576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering adeno-associated viruses for clinical gene therapy.
    Kotterman MA; Schaffer DV
    Nat Rev Genet; 2014 Jul; 15(7):445-51. PubMed ID: 24840552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and prospects of gene therapy clinical trials for the muscular dystrophies.
    Bengtsson NE; Seto JT; Hall JK; Chamberlain JS; Odom GL
    Hum Mol Genet; 2016 Apr; 25(R1):R9-17. PubMed ID: 26450518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoblast transfer therapy: is there any light at the end of the tunnel?
    Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
    Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapies to treat muscular dystrophy: progress to date.
    Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
    BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors.
    Stedman H; Wilson JM; Finke R; Kleckner AL; Mendell J
    Hum Gene Ther; 2000 Mar; 11(5):777-90. PubMed ID: 10757357
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges for gene therapy for muscular dystrophy.
    Mendell JR; Clark KR
    Curr Neurol Neurosci Rep; 2006 Jan; 6(1):47-56. PubMed ID: 16469271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscular dystrophy: from pathogenesis to strategy.
    Hsu YD
    Acta Neurol Taiwan; 2004 Jun; 13(2):50-8. PubMed ID: 15478675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of muscular dystrophy.
    Chamberlain JS
    Hum Mol Genet; 2002 Oct; 11(20):2355-62. PubMed ID: 12351570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapies for muscular dystrophy: cautious optimism.
    Cossu G; Sampaolesi M
    Trends Mol Med; 2004 Oct; 10(10):516-20. PubMed ID: 15464452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
    Wells DJ; Wells KE
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.